Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study

Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study

Introduction: Novel therapies are needed for the treatment of motion sickness given the inadequate relief and bothersome and dangerous adverse effects of currently approved therapies. Neurokinin-1 (NK1) receptor antagonists have the potential to be effective in improving the symptoms of motion sickn...

Full description

Bibliographic Details
Main Authors: Vasilios M. Polymeropoulos, Mark É. Czeisler, Mary M. Gibson, Austin A. Anderson, Jane Miglo, Jingyuan Wang, Changfu Xiao, Christos M. Polymeropoulos, Gunther Birznieks, Mihael H. Polymeropoulos
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Neurology
Subjects:
motion sickness
tradipitant
neurokinin-1
seasickness
seasickness prevention
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.563373/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.563373/full

Similar Items